Demonstrating cardiovascular (CV) benefits with lipid-lowering therapy (LLT) requires long-term randomized clinical trials (RCTs) with thousands of patients. Innovative approaches such as in silico ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results